{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:34:10Z","timestamp":1788820450280,"version":"build-2803163510"},"reference-count":265,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jconrel.2022.05.054","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:22:13Z","timestamp":1654906933000},"page":"397-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy"],"prefix":"10.1016","volume":"348","author":[{"given":"Rimsha","family":"Nooreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Nene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velpula","family":"Prasannanjaneyulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Chitlangya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Otavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra Kumar","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Singh","family":"Raghuvanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bala","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0005","first-page":"863","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0010","article-title":"Rheumatoid arthritis burden to increase by 10.6% over the next decade in the 8MM [Internet]","author":"GlobalData.","year":"2020","journal-title":"GlobalData."},{"issue":"15","key":"10.1016\/j.jconrel.2022.05.054_bb0015","article-title":"Prevalence trend and disparities in rheumatoid arthritis among us adults, 2005\u20132018","volume":"10","author":"Xu","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0020","article-title":"The impact of lifestyle behaviours, physical activity and smoking on morbidity and mortality in patients with rheumatoid arthritis","volume":"34","author":"Gwinnutt","year":"2020","journal-title":"Best Pract Res Clin Rheumatol [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0025","first-page":"1","article-title":"Treatment of rheumatoid arthritis: Unraveling the conundrum","volume":"65","author":"Zampeli","year":"2015","journal-title":"J Autoimmun [Internet]."},{"issue":"June","key":"10.1016\/j.jconrel.2022.05.054_bb0030","first-page":"595","article-title":"Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy","volume":"327","author":"Qindeel","year":"2020","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0035","first-page":"7291","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din Fud","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"October 2020","key":"10.1016\/j.jconrel.2022.05.054_bb0040","first-page":"102397","article-title":"Lipid based nanocarriers\u202f: A novel paradigm for topical antifungal therapy","volume":"62","author":"Nene","year":"2021","journal-title":"J Drug Deliv Sci Technol [Internet]"},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.054_bb0045","first-page":"2023","article-title":"Lipid based nanocarriers: a translational perspective","volume":"14","author":"Mishra","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol Med [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0050","first-page":"57","article-title":"Polymers in pharmaceutical drug delivery system: A review","volume":"14","author":"Gandhi","year":"2012","journal-title":"Int J Pharm Sci Rev Res."},{"issue":"41","key":"10.1016\/j.jconrel.2022.05.054_bb0055","article-title":"De C\u00e1ssia Bergamaschi C. Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review protocol","volume":"97","author":"Del Grossi","year":"2018","journal-title":"Med (United States)."},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2022.05.054_bb0060","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.054_bb0065","first-page":"581","article-title":"An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis","volume":"18","author":"Lu\u00eds","year":"2019","journal-title":"Expert Opin Drug Saf [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0070","first-page":"33","article-title":"Glucocorticoids and Rheumatoid Arthritis","volume":"42","author":"Ferreira","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0075","first-page":"502","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem [Internet]."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0080","first-page":"133","article-title":"Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis","volume":"15","author":"Alfaro-Lara","year":"2019","journal-title":"Reumatol Clin [Internet]."},{"issue":"10","key":"10.1016\/j.jconrel.2022.05.054_bb0085","first-page":"1326","article-title":"Low persistence rates in patients with rheumatoid arthritis treated with triple therapy and adverse drug events associated with sulfasalazine","volume":"71","author":"Erhardt","year":"2019","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.jconrel.2022.05.054_bb0090","first-page":"433","article-title":"Etanercept for the treatment of rheumatoid arthritis","volume":"10","author":"Zhao","year":"2018","journal-title":"Immunotherapy."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0095","first-page":"307","article-title":"Certolizumab pegol for the treatment of psoriatic arthritis","volume":"11","author":"Baronaite Hansen","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.054_bb0100","first-page":"727","article-title":"Anakinra for the treatment of rheumatoid arthritis: a safety evaluation","volume":"17","author":"Ram\u00edrez","year":"2018","journal-title":"Expert Opin Drug Saf [Internet]."},{"issue":"8","key":"10.1016\/j.jconrel.2022.05.054_bb0105","first-page":"780","article-title":"Sarilumab: review of a second IL-6 receptor antagonist indicated for the treatment of rheumatoid arthritis","volume":"52","author":"Boyce","year":"2018","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0110","first-page":"319","article-title":"Abatacept for the treatment of rheumatoid arthritis","volume":"15","author":"Pombo-Suarez","year":"2019","journal-title":"Expert Rev Clin Immunol [Internet]."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb0115","first-page":"2977","article-title":"A comprehensive review of rituximab therapy in rheumatoid arthritis patients","volume":"38","author":"Tavakolpour","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.054_bb0120","first-page":"1","article-title":"JAK-inhibitors for the treatment of rheumatoid arthritis: A focus on the present and an outlook on the future","volume":"10","author":"Angelini","year":"2020","journal-title":"Biomolecules."},{"issue":"9","key":"10.1016\/j.jconrel.2022.05.054_bb0125","first-page":"947","article-title":"Baricitinib: the second FDA-Approved JAK inhibitor for the treatment of Rheumatoid Arthritis","volume":"53","author":"Mogul","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0130","first-page":"1","article-title":"JAK inhibitors and infections risk: focus on herpes zoster","volume":"12","author":"Sunzini","year":"2020","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.054_bb0135","first-page":"1013","article-title":"Rheumatology in India: A bird\u2019s eye view on organization, epidemiology, training programs and publications","volume":"31","author":"Misra","year":"2016","journal-title":"J. Korean Med. Sci."},{"issue":"December 2018","key":"10.1016\/j.jconrel.2022.05.054_bb0140","first-page":"8","article-title":"Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review","volume":"702","author":"Karami","year":"2019","journal-title":"Gene [Internet]."},{"issue":"JUN","key":"10.1016\/j.jconrel.2022.05.054_bb0145","first-page":"1","article-title":"Epigenetic changes in the pathogenesis of rheumatoid arthritis","volume":"10","author":"Nemtsova","year":"2019","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0150","first-page":"174","article-title":"Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis","volume":"32","author":"van der Woude","year":"2018","journal-title":"Best Pract Res Clin Rheumatol [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0155","article-title":"Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis","volume":"2017","author":"Horta-Baas","year":"2017","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0160","first-page":"165","article-title":"Epstein-Barr virus and rheumatoid arthritis","volume":"85","author":"Balandraud","year":"2018","journal-title":"Jt Bone Spine [Internet]."},{"issue":"02","key":"10.1016\/j.jconrel.2022.05.054_bb0165","first-page":"87","article-title":"Association of Parvovirus B19 with rheumatic diseases","volume":"21","author":"Au","year":"2021","journal-title":"J Clin Rheumatol Immunol."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0170","first-page":"1","article-title":"CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection [version 1; peer review: 2 approved]","volume":"8","author":"Bano","year":"2019","journal-title":"F1000Research."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0175","first-page":"224","article-title":"The gut\u2013joint axis in rheumatoid arthritis","volume":"17","author":"Zaiss","year":"2021","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0180","first-page":"259","article-title":"The role of diet in rheumatoid arthritis","volume":"56","author":"Skoczy\u0144ska","year":"2018","journal-title":"Reumatologia."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0185","first-page":"266","article-title":"Long-term exposure to outdoor air pollution and the risk of development of rheumatoid arthritis: A systematic review and meta-analysis","volume":"50","author":"Di","year":"2020","journal-title":"Semin Arthritis Rheum [Internet]."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb0190","first-page":"951","article-title":"Silica dust exposure increases risk for rheumatoid arthritis: a Swedish national registry case-control study","volume":"63","author":"Wrangel","year":"2021","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0195","first-page":"615","article-title":"Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0200","article-title":"The etiology of rheumatoid arthritis","volume":"110","author":"Scherer","year":"2020","journal-title":"J. Autoimmun."},{"issue":"21","key":"10.1016\/j.jconrel.2022.05.054_bb0205","first-page":"1","article-title":"Modeling rheumatoid arthritis in vitro: from experimental feasibility to physiological proximity","volume":"21","author":"Damerau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.jconrel.2022.05.054_bb0210","first-page":"2205","article-title":"Mechanism of disease the pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0215","first-page":"437","article-title":"The role of autoantibodies in the pathophysiology of rheumatoid arthritis","volume":"39","author":"Derksen","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"10086","key":"10.1016\/j.jconrel.2022.05.054_bb0220","first-page":"2338","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet [Internet]."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2022.05.054_bb0225","first-page":"3","article-title":"New insights into the pathogenesis of rheumatoid arthritis","volume":"39","author":"Weyand","year":"2000","journal-title":"Rheumatology."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0230","first-page":"301","article-title":"Immune mechanisms and novel targets in rheumatoid arthritis","volume":"37","author":"Venuturupalli","year":"2017","journal-title":"Immunol Allergy Clin North Am [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0235","first-page":"615","article-title":"Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed Pharmacother [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0240","first-page":"10","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0245","first-page":"1","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets","volume":"1","author":"Alunno","year":"2017","journal-title":"BMC Rheumatol."},{"issue":"10086","key":"10.1016\/j.jconrel.2022.05.054_bb0250","first-page":"2328","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet [Internet]."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0255","first-page":"775","article-title":"Synovial IL-21\/TNF-producing CD4 + T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes","volume":"101","author":"Lebre","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.jconrel.2022.05.054_bb0260","first-page":"731","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0265","first-page":"175","article-title":"The role of the synovial fibroblast in rheumatoid arthritis pathogenesis","volume":"27","author":"Turner","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0270","first-page":"170","article-title":"Proteinases and their receptors in inflammatory arthritis: an overview","volume":"14","author":"Oikonomopoulou","year":"2018","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"12","key":"10.1016\/j.jconrel.2022.05.054_bb0275","first-page":"1414","article-title":"Synovial fibroblasts spread rheumatoid arthritis to unaffected joints","volume":"15","author":"Lef\u00e8vre","year":"2009","journal-title":"Nat Med [Internet]."},{"issue":"July","key":"10.1016\/j.jconrel.2022.05.054_bb0280","first-page":"1","article-title":"Hypoxia-inducible factor is critical for pathogenesis and regulation of immune cell functions in rheumatoid arthritis","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0285","first-page":"1","article-title":"Hypoxia and its implications in rheumatoid arthritis","volume":"23","author":"Qui\u00f1onez-Flores","year":"2016","journal-title":"J Biomed Sci [Internet]."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0290","first-page":"433","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0295","first-page":"345","article-title":"Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts","volume":"14","author":"Honorati","year":"2006","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb0300","article-title":"MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact","volume":"18","author":"Evangelatos","year":"2019","journal-title":"Autoimmun Rev [Internet]."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0305","first-page":"916","article-title":"Tumor necrosis factor \u03b1-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-\u03baB signaling","volume":"65","author":"Trenkmann","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0310","first-page":"373","article-title":"Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation","volume":"63","author":"Stanczyk","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0315","first-page":"234","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat Rev Drug Discov [Internet]."},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0320","first-page":"850","article-title":"Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis","volume":"57","author":"Alunno","year":"2018","journal-title":"Rheumatol (United Kingdom)."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0325","first-page":"9","article-title":"RANKL: a therapeutic target for bone destruction in rheumatoid arthritis","volume":"28","author":"Tanaka","year":"2018","journal-title":"Mod Rheumatol [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0330","first-page":"102741","article-title":"An overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions","volume":"20","author":"Ilchovska","year":"2021","journal-title":"Autoimmun Rev [Internet]."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb0335","first-page":"656","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0340","first-page":"110","article-title":"Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system","volume":"40","author":"Tanaka","year":"2018","journal-title":"Curr Opin Pharmacol [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0345","first-page":"87","article-title":"Immune resolution mechanisms in inflammatory arthritis","volume":"13","author":"Perretti","year":"2017","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0350","first-page":"9","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0355","first-page":"365","article-title":"Selected cytokine pathways in rheumatoid arthritis","volume":"39","author":"Noack","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0360","article-title":"Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"June","key":"10.1016\/j.jconrel.2022.05.054_bb0365","first-page":"1","article-title":"Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis","volume":"6","author":"Remuzgo-Mart\u00ednez","year":"2016","journal-title":"Sci Rep [Internet]."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0370","first-page":"343","article-title":"Cellular and molecular perspectives in rheumatoid arthritis","volume":"39","author":"Veale","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0375","first-page":"63","article-title":"Cytokines in rheumatoid arthritis-shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0380","article-title":"Rheumatoid arthritis: Extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0385","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0390","first-page":"1","article-title":"The extra-articular impacts of rheumatoid arthritis: Moving towards holistic care","volume":"2","author":"Scott","year":"2018","journal-title":"BMC Rheumatol."},{"issue":"10","key":"10.1016\/j.jconrel.2022.05.054_bb0395","first-page":"951","article-title":"Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: Diagnosis and options for treatment","volume":"28","author":"Muramatsu","year":"2008","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.jconrel.2022.05.054_bb0400","first-page":"1","article-title":"Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: Report of 6 cases and literature review","volume":"9","author":"Trabelsi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0405","first-page":"500","article-title":"Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents","volume":"32","author":"Atzeni","year":"2018","journal-title":"Best Pract Res Clin Rheumatol [Internet]."},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0410","first-page":"1171","article-title":"Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors","volume":"37","author":"Petersen","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0415","first-page":"89","article-title":"Gastrointestinal and hepatic disease in rheumatoid arthritis","volume":"44","author":"Craig","year":"2018","journal-title":"Rheum Dis Clin North Am [Internet]."},{"issue":"00","key":"10.1016\/j.jconrel.2022.05.054_bb0420","first-page":"1","article-title":"Proliferative diffuse glomerulonephritis in rheumatoid","volume":"00","author":"Cavallasca","year":"2017","journal-title":"Arthritis."},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0425","first-page":"733","article-title":"Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome","volume":"36","author":"Klein","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0430","first-page":"1","article-title":"Endothelial dysfunction and extra-articular neurological manifestations in rheumatoid arthritis","volume":"11","author":"Maiuolo","year":"2021","journal-title":"Biomolecules."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0435","first-page":"1","article-title":"Polymeric engineering of nanoparticles for highly efficient multifunctional drug delivery systems","volume":"9","author":"Fortuni","year":"2019","journal-title":"Sci Rep [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0440","first-page":"31","article-title":"Recent developments in natural and synthetic polymeric drug delivery systems used for the treatment of osteoarthritis","volume":"123","author":"Rahimi","year":"2021","journal-title":"Acta Biomater [Internet]."},{"issue":"10","key":"10.1016\/j.jconrel.2022.05.054_bb0445","first-page":"996","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0450","first-page":"429","article-title":"Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0455","first-page":"1","article-title":"Polymeric controlled drug-delivery systems: Perspective issues and opportunities","volume":"27","author":"Kumar","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"January","key":"10.1016\/j.jconrel.2022.05.054_bb0460","first-page":"152","article-title":"Polymer nanotherapeutics to correct autoimmunity","volume":"343","author":"Su","year":"2022","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0465","first-page":"17","article-title":"Immunomodulatory nanosystems","volume":"6","author":"Feng","year":"2019","journal-title":"Adv Sci."},{"issue":"16","key":"10.1016\/j.jconrel.2022.05.054_bb0470","first-page":"1585","article-title":"Tackling autoimmunity with nanomedicines","volume":"15","author":"Feng","year":"2020","journal-title":"Nanomedicine."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0475","first-page":"1","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0480","series-title":"Polymeric nanoparticles [Internet]. Nanoparticles for Biomedical Applications: Fundamental Concepts, Biological Interactions and Clinical Applications","first-page":"303","author":"Jarai","year":"2019"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0485","article-title":"Recent developments in functionalized polymer nanoparticles for efficient drug delivery system","volume":"20","author":"Sur","year":"2019","journal-title":"Nano-Structures and Nano-Objects [Internet]."},{"issue":"April","key":"10.1016\/j.jconrel.2022.05.054_bb0490","first-page":"1","article-title":"Multifunctional polymeric micelles for delivery of drugs and siRNA","volume":"5","author":"Jhaveri","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0495","series-title":"Recent Advances in Development of Nano Drug Delivery [Internet]. Applications of Targeted Nano Drugs and Delivery Systems: Nanoscience and Nanotechnology in Drug Delivery","first-page":"93","author":"Rana","year":"2018"},{"issue":"7","key":"10.1016\/j.jconrel.2022.05.054_bb0500","first-page":"1198","article-title":"Dendrimers in medicine: therapeutic concepts and pharmaceutical challenges","volume":"26","author":"Wu","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0505","first-page":"3","article-title":"Drug-dendrimer interactions and toxicity","volume":"6","author":"Madaan","year":"2014"},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0510","first-page":"840","article-title":"Polymeric conjugates for drug delivery","volume":"24","author":"Larson","year":"2012","journal-title":"Chem. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2022.05.054_bb0515","first-page":"915","article-title":"Polymer \u2013 drug conjugates for novel molecular targets","volume":"5","author":"Sanchis","year":"2010","journal-title":"Nanomedicine."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb0520","first-page":"1","article-title":"Microneedles: Characteristics, materials, production methods and commercial development","volume":"11","author":"Tucak","year":"2020","journal-title":"Micromachines."},{"issue":"1\u20134","key":"10.1016\/j.jconrel.2022.05.054_bb0525","first-page":"1","article-title":"Stimuli-responsive polymers and their applications in nanomedicine","volume":"7","author":"Cabane","year":"2012","journal-title":"Biointerphases."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0530","first-page":"1","article-title":"Nanoparticles-a historical perspective","volume":"331","author":"Kreuter","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0535","first-page":"93","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2022.05.054_bb0540","first-page":"239","article-title":"A holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat Rev Drug Discov [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0545","first-page":"1","article-title":"Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis","volume":"18","author":"Yan","year":"2020","journal-title":"J Nanobiotechnology [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0550","series-title":"Artificial Cells, Nanomedicine and Biotechnology","first-page":"502","article-title":"Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment","volume":"vol. 46","author":"Pirmardvand Chegini","year":"2018"},{"issue":"February","key":"10.1016\/j.jconrel.2022.05.054_bb0555","first-page":"1","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"March","key":"10.1016\/j.jconrel.2022.05.054_bb0560","first-page":"105","article-title":"Biodegradable polymeric nanoparticles for therapeutic cancer treatments","volume":"9","author":"Karlsson","year":"2018","journal-title":"Annu Rev Chem Biomol Eng."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0565","first-page":"249","article-title":"Formation of novel polymeric nanoparticles","volume":"34","author":"Zhang","year":"2001","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0570","article-title":"Development of methotrexate and minocycline loaded nanoparticles for the effective treatment of rheumatoid arthritis","volume":"21","author":"Janakiraman","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.jconrel.2022.05.054_bb0575","first-page":"888","article-title":"Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose","volume":"38","author":"Calabrese","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0580","first-page":"103","article-title":"Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis","author":"Trujillo-Nolasco","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"issue":"March","key":"10.1016\/j.jconrel.2022.05.054_bb0585","article-title":"Evaluation of Encapsulated Eugenol by Chitosan Nanoparticles on the aggressive model of rheumatoid arthritis","volume":"85","author":"Jabbari","year":"2020","journal-title":"Int Immunopharmacol [Internet]."},{"issue":"596","key":"10.1016\/j.jconrel.2022.05.054_bb0590","article-title":"PLGA\/PCADK composite microspheres containing hyaluronic acid\u2013chitosan siRNA nanoparticles: A rational design for rheumatoid arthritis therapy","volume":"December 2020","author":"Zhao","year":"2021","journal-title":"Int J Pharm [Internet]."},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0595","first-page":"2233","article-title":"Polyketal nanoparticles co-loaded with miR-124 and Ketoprofen for treatment of rheumatoid arthritis","volume":"110","author":"Zhao","year":"2021","journal-title":"J Pharm Sci [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0600","first-page":"502","article-title":"Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis","volume":"171","author":"Pandey","year":"2021","journal-title":"Int J Biol Macromol [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0605","article-title":"Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis","author":"Heo","year":"2017","journal-title":"Biomaterials [Internet]."},{"issue":"258","key":"10.1016\/j.jconrel.2022.05.054_bb0610","article-title":"Aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles alleviate inflammation in rheumatoid arthritis\u202f: A combinational therapeutic approach","volume":"December 2020","author":"Ansari","year":"2021","journal-title":"Carbohydr Polym [Internet]."},{"issue":"May","key":"10.1016\/j.jconrel.2022.05.054_bb0615","article-title":"Targeting CD34 + cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis","volume":"103","author":"Colombo","year":"2019","journal-title":"J Autoimmun [Internet]."},{"issue":"September 2020","key":"10.1016\/j.jconrel.2022.05.054_bb0620","first-page":"127","article-title":"Polymeric micelles in cancer therapy: state of the art","volume":"332","author":"Ghosh","year":"2021","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0625","first-page":"201","article-title":"Block and graft copolymer micelles in solution","volume":"6","author":"Tuzar","year":"1976","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0630","first-page":"101","article-title":"Polymeric micelles - a new generation of colloidal drug carriers","volume":"48","author":"Jones","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0635","article-title":"Polymeric micelles of biodegradable diblock copolymers\u202f: enhanced encapsulation of hydrophobic","author":"Hussein","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0640","article-title":"Polymeric micelles: Basic research to clinical practice","author":"Deshmukh","year":"2017","journal-title":"Int J Pharm [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0645","series-title":"RSC Advances","first-page":"17028","article-title":"Polymeric micelles as drug delivery vehicles","volume":"Vol. 4","author":"Ahmad","year":"2014"},{"issue":"6","key":"10.1016\/j.jconrel.2022.05.054_bb0650","first-page":"714","article-title":"Advances in polymeric micelles for drug delivery and tumor targeting","volume":"6","author":"Kedar","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol Med [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0655","first-page":"64","article-title":"Targeted delivery of low-dose dexamethasone using PCL \u2013 PEG micelles for effective treatment of rheumatoid arthritis","volume":"230","author":"Wang","year":"2016","journal-title":"J Control Release [Internet]."},{"issue":"October 2019","key":"10.1016\/j.jconrel.2022.05.054_bb0660","first-page":"111042","article-title":"Therapeutic e ff ects of celecoxib polymeric systems in rat models of in fl ammation and adjuvant-induced rheumatoid arthritis","volume":"114","author":"Seok","year":"2020","journal-title":"Mater Sci Eng C [Internet]"},{"issue":"March","key":"10.1016\/j.jconrel.2022.05.054_bb0665","article-title":"Colloids and Surfaces B\u202f: Biointerfaces Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles\u202f: In vivo results","volume":"206","author":"Monteiro","year":"2021"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.05.054_bb0670","first-page":"315","article-title":"Systemic delivery of small interfering RNA targeting nuclear factor k B in mice with collagen-induced arthritis using arginine-histidine -cysteine based oligopeptide-modi fi ed polymer nanomicelles","volume":"515","author":"Kanazawa","year":"2016","journal-title":"Int J Pharm [Internet]."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0675","first-page":"708","article-title":"Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0680","series-title":"Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: a randomized, double - blind, controlled trial","first-page":"1","volume":"August","author":"Javadi","year":"2019"},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0685","first-page":"1","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"issue":"9","key":"10.1016\/j.jconrel.2022.05.054_bb0690","first-page":"1","article-title":"Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy","volume":"22","author":"Mendes","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0695","series-title":"Poly (amidoamine) Dendrimer Complexes as a Platform for Gene Delivery","first-page":"1687","author":"Shcharbin","year":"2013"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0700","article-title":"Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals","volume":"278","author":"Yousefi","year":"2020","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"July","key":"10.1016\/j.jconrel.2022.05.054_bb0705","article-title":"Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery","volume":"158","author":"Singh","year":"2021","journal-title":"Eur Polym J [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0710","series-title":"New Advances in General Biomedical Applications of","first-page":"1","volume":"27","author":"Vinicius","year":"2018"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0715","series-title":"Structural Features of Fr echet-Type Dendrons and Dendrimers in Single Crystals","author":"Mihail","year":"2010"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0720","article-title":"Dendritic core-shell systems as soft drug delivery nanocarriers","author":"Lukowiak","year":"2015","journal-title":"Biotechnol Adv [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0725","first-page":"107","article-title":"Synthesis, properties and application as a possible drug delivery systems dendrimers \u2013 A review","volume":"8","author":"Salvi","year":"2020","journal-title":"Asian J Pharm Res Dev."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0730","series-title":"Complex Dendrimer \u00c0 Lyotropic Liquid Crystalline Systems\u202f: Structural Behavior and Interactions","first-page":"11984","author":"Bitan-cherbakovsky","year":"2011"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0735","first-page":"2017","article-title":"Biodegradable dendrimers for drug delivery","author":"Huang","year":"2018","journal-title":"Mater Sci Eng C [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0740","series-title":"Polyester Dendrimers: Smart Carriers for Drug Delivery","first-page":"179","author":"Grindley","year":"2014"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0745","first-page":"2215","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0750","first-page":"707","article-title":"Dendrimers: A versatile nanocarrier for drug delivery and targeting","volume":"548","author":"Sherje","year":"2018","journal-title":"Int J Pharm [Internet]."},{"issue":"9","key":"10.1016\/j.jconrel.2022.05.054_bb0755","first-page":"745","article-title":"In vivo proinflammatory activity of generations 0\u20133 (G0\u2013G3) polyamidoamine (PAMAM) nanoparticles","volume":"65","author":"Durocher","year":"2016","journal-title":"Inflamm. Res."},{"issue":"December 2020","key":"10.1016\/j.jconrel.2022.05.054_bb0760","article-title":"PAMAM dendrimers functionalised with an anti-TNF \u03b1 antibody and chondroitin sulphate for treatment of rheumatoid arthritis","volume":"121","author":"Oliveira","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"issue":"20","key":"10.1016\/j.jconrel.2022.05.054_bb0765","first-page":"4211","article-title":"Modulation of inflammation by anti-TNF \u03b1 mAb-dendrimer nanoparticles loaded in tyramine-modified gellan gum hydrogels in a cartilage-on-a-chip model","volume":"9","author":"Oliveira","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"March","key":"10.1016\/j.jconrel.2022.05.054_bb0770","first-page":"959","article-title":"Pyrrolidone-modified PAMAM dendrimers enhance anti-inflammatory potential of indomethacin in vitro","volume":"181","author":"Gorzkiewicz","year":"2019","journal-title":"Colloids Surfaces B Biointerfaces [Internet]."},{"issue":"49","key":"10.1016\/j.jconrel.2022.05.054_bb0775","first-page":"1","article-title":"Targeted combination of antioxidative and anti-inflammatory therapy of rheumatoid arthritis using multifunctional dendrimer-entrapped gold nanoparticles as a platform","volume":"16","author":"Li","year":"2020","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0780","first-page":"61","article-title":"Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal- and photodynamic- therapy of rheumatoid arthritis","volume":"544","author":"Pandey","year":"2019","journal-title":"J Colloid Interface Sci [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0785","first-page":"331","article-title":"Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties","volume":"31","author":"Couvreur","year":"1979","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.05.054_bb0790","first-page":"113","article-title":"Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-Huertas","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0795","first-page":"259","article-title":"A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes","volume":"65","author":"Letchford","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0800","article-title":"Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications","volume":"2","author":"Guterres","year":"2007","journal-title":"Drug Target Insights."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0805","first-page":"1027","article-title":"Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy","volume":"8","author":"Labib","year":"1991","journal-title":"Pharmaceut. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0810","first-page":"223","article-title":"PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics","volume":"46","author":"Peracchia","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0815","series-title":"Poly (lactic acid-co-glycolic acid) Nanospheres Improved the Oral Delivery of Candesartan Cilexetil","author":"Nair","year":"2017"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.05.054_bb0820","first-page":"196","article-title":"Polymeric nanospheres for topical delivery of vitamin D3","volume":"516","author":"Ramezanli","year":"2017","journal-title":"Int J Pharm [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0825","first-page":"1","article-title":"pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model","volume":"72","author":"Makhlof","year":"2009","journal-title":"Eur J Pharm Biopharm [Internet]."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb0830","first-page":"84","article-title":"Nanospheres: a novel approach for targeted drug delivery system","volume":"5","author":"Singh","year":"2010","journal-title":"Int J Pharm Sci Rev Res."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0835","first-page":"6603","article-title":"Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model","volume":"10","author":"Boechat","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0840","first-page":"163","article-title":"A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: in vivo studies","volume":"78","author":"Coradini","year":"2015","journal-title":"Eur J Pharm Sci [Internet]."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0845","first-page":"1265","article-title":"Lipid-core nanocapsules improved antiedematogenic activity of tacrolimus in adjuvant-induced arthritis model","volume":"16","author":"Friedrich","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"October","key":"10.1016\/j.jconrel.2022.05.054_bb0850","first-page":"110958","article-title":"Anti-inflammatory effect of nano-encapsulated nerolidol on zymosan-induced arthritis in mice","volume":"135","author":"Soares","year":"2020","journal-title":"Food Chem Toxicol [Internet]."},{"issue":"10","key":"10.1016\/j.jconrel.2022.05.054_bb0855","first-page":"1346","article-title":"Therapeutic potential of targeted-gold nanospheres on collagen-induced arthritis in rats","volume":"48","author":"Shahen","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0860","first-page":"27","article-title":"Peptamin (glycyl-l-leucyl-mescaline) bound to blood plasma expander (polyvinylpyrrolidone) as a new depot form of a biologically active primary amine (mescaline)","volume":"10B","author":"Jatzkewitz","year":"1955","journal-title":"Z. Naturforsch."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0865","article-title":"Polymer\u2013drug conjugate therapeutics: advances, insights and prospects","author":"Ekladious","year":"1982","journal-title":"Nat Rev Drug Discov [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0870","series-title":"Polymer \u2013 Drug Conjugates\u202f: Origins Progress to Date and Future Directions \u2606","author":"Chemistry","year":"2012"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0875","series-title":"Naturapolyceutics: The Science of Utilizing Natural Polymers for Drug Delivery","first-page":"1312","author":"Ngwuluka","year":"2014"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0880","series-title":"Polymer Conjugates for Drug Delivery","first-page":"114","author":"Larson","year":"2005"},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0885","article-title":"Scavenger receptor-mediated targeted treatment of collagen-induced arthritis by dextran sulfate \u2212 methotrexate prodrug","volume":"7","author":"Yang","year":"2017","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0890","first-page":"3","article-title":"Optimized in vivo performance of acid-liable micelles for the treatment of rheumatoid arthritis by one single injection","volume":"12","author":"Wang","year":"2019"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0895","series-title":"A Hyaluronic Acid \u2013 Methotrexate Conjugate for Targeted Therapy of Rheumatoid Arthritis \u2020","author":"Shin","year":"2014"},{"issue":"12","key":"10.1016\/j.jconrel.2022.05.054_bb0900","first-page":"1205","article-title":"Development of macromolecular prodrug for rheumatoid arthritis","volume":"64","author":"Yuan","year":"2012","journal-title":"Adv Drug Deliv Rev [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0905","series-title":"Syntheses of Click PEG - Dexamethasone Conjugates for the Treatment of Rheumatoid Arthritis","first-page":"2621","author":"Ming","year":"2010"},{"issue":"34","key":"10.1016\/j.jconrel.2022.05.054_bb0910","first-page":"9057","article-title":"Biomaterials Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis","volume":"31","author":"Jeong","year":"2010","journal-title":"Biomaterials [Internet]."},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb0915","first-page":"581","article-title":"Microneedles for transdermal drug delivery","volume":"56","author":"Prausnitz","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0920","article-title":"Polymeric-based microneedle arrays as potential platforms in the development of drugs delivery systems","author":"Meng","year":"2020","journal-title":"J Adv Res [Internet]."},{"issue":"0","key":"10.1016\/j.jconrel.2022.05.054_bb0925","first-page":"1","article-title":"Review SC","volume":"0","author":"Lisa","year":"2020","journal-title":"Expert Opin Ther Pat [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0930","first-page":"11","article-title":"Microneedle, bio-microneedle and bio-inspired microneedle: a review","volume":"251","author":"Ma","year":"2017","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0935","series-title":"Translation of Polymeric Microneedles for Treatment of Human Diseases\u202f: Recent Trends, Progress, and Challenges","first-page":"1","author":"Yadav","year":"2021"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0940","first-page":"106","article-title":"Polymeric microneedles for transdermal protein delivery","volume":"127","author":"Ye","year":"2018","journal-title":"Adv Drug Deliv Rev [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0945","article-title":"Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques","volume":"11","author":"Asfour","year":"2021","journal-title":"Drug Deliv Transl. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2022.05.054_bb0950","first-page":"447","article-title":"Microneedles for vaccine delivery: Challenges and future perspectives","volume":"8","author":"Shin","year":"2017","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0955","first-page":"7","article-title":"Microneedle technology for advanced drug delivery\u202f: evolving vistas","volume":"9","author":"Bora","year":"2008","journal-title":"Crips."},{"issue":"August","key":"10.1016\/j.jconrel.2022.05.054_bb0960","first-page":"676","article-title":"Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin","volume":"337","author":"Lee","year":"2021","journal-title":"J Control Release [Internet]."},{"issue":"February","key":"10.1016\/j.jconrel.2022.05.054_bb0965","first-page":"1","article-title":"Transdermal delivery of siRNA through microneedle array","volume":"6","author":"Deng","year":"2016","journal-title":"Sci Rep [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb0970","first-page":"130","article-title":"Current advances in the fabrication of microneedles for transdermal delivery","volume":"185","author":"Indermun","year":"2014","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0975","article-title":"Jo ur l P of","author":"Chen","year":"2020","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb0980","series-title":"Recent Advances of Microneedles and Their Application in Disease Treatment","author":"Zhang","year":"2022"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0985","series-title":"Engineered Microneedle Patches for Controlled Release of Active Compounds\u202f: Recent Advances in Release Profile Tuning","first-page":"1","volume":"2000171","author":"Jamaledin","year":"2020"},{"key":"10.1016\/j.jconrel.2022.05.054_bb0990","series-title":"Mini-Review Transdermal Microneedles \u2014 A Materials Perspective","author":"Ali","year":"2020"},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb0995","first-page":"227","article-title":"Micro-scale devices for transdermal drug delivery","volume":"364","author":"Arora","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"July","key":"10.1016\/j.jconrel.2022.05.054_bb1000","first-page":"537","article-title":"Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment","volume":"336","author":"Du","year":"2021","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1005","article-title":"Development and characterisation of novel poly (vinyl alcohol)\/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate","volume":"119580","author":"Tekko","year":"2020","journal-title":"Int J Pharm [Internet]."},{"issue":"November 2018","key":"10.1016\/j.jconrel.2022.05.054_bb1010","first-page":"91","article-title":"Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin\u202f: A biocomfortable attempt to treat Rheumatoid Arthritis","volume":"563","author":"Yao","year":"2019","journal-title":"Int J Pharm [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1015","series-title":"Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment","first-page":"1","author":"Cao","year":"2021"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1020","series-title":"Drug Development and Industrial Pharmacy","first-page":"000","author":"Yanmei","year":"2021"},{"issue":"51","key":"10.1016\/j.jconrel.2022.05.054_bb1025","first-page":"114","article-title":"European Journal of Pharmaceutical Sciences Statistically optimized fast dissolving microneedle transdermal patch of meloxicam\u202f: A patient friendly approach to manage arthritis","volume":"104","author":"Amodwala","year":"2017","journal-title":"Eur J Pharm Sci [Internet]."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb1030","first-page":"991","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater [Internet]."},{"issue":"4374","key":"10.1016\/j.jconrel.2022.05.054_bb1035","first-page":"1290","article-title":"Design of liposomes for enhanced local release of drugs by hyperthermia","volume":"202","author":"Yatvin","year":"1978","journal-title":"Science (80- )."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1040","series-title":"Stimuli-responsive polymers as smart drug delivery systems: Classifications based on carrier type and triggered-release mechanism [Internet]. Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications: Volume 1: Types and Triggers","first-page":"43","author":"Indermun","year":"2018"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1045","first-page":"1","article-title":"Stimulus-responsive polymeric nanogels as smart drug delivery systems","volume":"92","author":"Hajebi","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1050","article-title":"Nanomedicines for the treatment of rheumatoid arthritis\u202f: State of art and potential therapeutic strategies","author":"Wang","year":"2021","journal-title":"Acta Pharm Sin B [Internet]."},{"issue":"12","key":"10.1016\/j.jconrel.2022.05.054_bb1055","first-page":"2910","article-title":"Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis","volume":"25","author":"Liu","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1060","first-page":"133","article-title":"pH-sensitive polymeric micelles for targeted delivery to inflamed joints","volume":"246","author":"Li","year":"2017","journal-title":"J Control Release [Internet]."},{"issue":"April","key":"10.1016\/j.jconrel.2022.05.054_bb1065","first-page":"1","article-title":"Synthesis and characterization of redox-sensitive polyurethanes based on L-glutathione oxidized and poly(ether ester) triblock copolymers","volume":"166","author":"Palumbo","year":"2021","journal-title":"React. Funct. Polym."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb1070","first-page":"670","article-title":"Redox distress and genetic defects conspire in systemic autoinflammatory diseases","volume":"11","author":"Varga","year":"2015","journal-title":"Nat Rev Rheumatol [Internet]."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb1075","article-title":"Stimuli-responsive drug release from smart polymers","volume":"10","author":"Wells","year":"2019","journal-title":"J Funct Biomater."},{"issue":"62","key":"10.1016\/j.jconrel.2022.05.054_bb1080","first-page":"6974","article-title":"PEG-sheddable polyplex micelles as smart gene carriers based on MMP-cleavable peptide-linked block copolymers","volume":"49","author":"Li","year":"2013","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb1085","first-page":"454","article-title":"Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis","volume":"29","author":"Yu","year":"2022","journal-title":"Drug Deliv [Internet]."},{"issue":"July","key":"10.1016\/j.jconrel.2022.05.054_bb1090","first-page":"136","article-title":"Study of double-targeting nanoparticles loaded with MCL-1 siRNA and dexamethasone for adjuvant-induced arthritis therapy","volume":"154","author":"Li","year":"2020","journal-title":"Eur J Pharm Biopharm [Internet]."},{"issue":"December 2019","key":"10.1016\/j.jconrel.2022.05.054_bb1095","article-title":"Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2\/TNF-\u03b1\/BAFF signaling pathway","volume":"232","author":"Ni","year":"2020","journal-title":"Biomaterials [Internet]."},{"issue":"1","key":"10.1016\/j.jconrel.2022.05.054_bb1100","first-page":"1","article-title":"Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis","volume":"12","author":"Deng","year":"2021","journal-title":"Nat. Commun."},{"issue":"June","key":"10.1016\/j.jconrel.2022.05.054_bb1105","first-page":"39","article-title":"European Journal of Pharmaceutics and Biopharmaceutics Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis","volume":"130","author":"Zhao","year":"2018","journal-title":"Eur J Pharm Biopharm [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1110","series-title":"Hyaluronic Acid Coated Acid-Sensitive Nanoparticles for Targeted Therapy of Adjuvant-Induced Arthritis in Rats","author":"Yu","year":"2019"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1115","article-title":"Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles","author":"Sim\u00f3n-V\u00e1zquez","year":"2022","journal-title":"Drug Deliv Transl Res [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1120","first-page":"2051","article-title":"Fabrication of a triptolide-loaded and poly-\u03b3-Glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1125","first-page":"1215","article-title":"PEGylated PLGA nanoparticle delivery of eggmanone for T cell modulation: Applications in rheumatic autoimmunity","volume":"15","author":"Haycook","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1130","first-page":"4781","article-title":"Potential privilege of maltodextrin- \u03b1 -tocopherol nano-micelles in seizing tacrolimus renal toxicity, managing rheumatoid arthritismand accelerating bone regeneration","volume":"16","author":"Helal","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1135","series-title":"Therapeutic Effects of Lornoxicam-Loaded Nanomicellar Formula in Experimental Models of Rheumatoid Arthritis","first-page":"7015","author":"Press","year":"2017"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1140","article-title":"Indomethacin loaded dextran stearate polymeric micelles improve adjuvant - induced arthritis in rats\u202f: design and in vivo evaluation","author":"Reza","year":"2020","journal-title":"Inflammopharmacology [Internet]."},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb1145","first-page":"1","article-title":"Systemic Delivery of Small Interfering RNA Targeting the Interleukin-2 \/ 15 Receptor b Chain Prevents Disease Progression in Experimental","volume":"8","author":"Zhang","year":"2013","journal-title":"Arthritis."},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb1150","first-page":"143","article-title":"Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis","volume":"171","author":"Seok","year":"2013","journal-title":"J Control Release [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1155","series-title":"Transepidermal Micro Needles for co-Administration of Folic Acid with Methotrexate in the Treatment of Rheumatoid Arthritis Transepidermal Microneedles for co-Administration of Folic Acid with Methotrexate in the Treatment of Rheumatoid Arthritis","author":"Shende","year":"2019"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1160","first-page":"1","article-title":"Development of sinomenine hydrochloride-loaded polyvinylalcohol \/ maltose microneedle for transdermal delivery","volume":"35","author":"Cao","year":"2016","journal-title":"J Drug Deliv Sci Technol [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1165","series-title":"Novel DEK-Targeting Aptamer Delivered by a Hydrogel Microneedle Attenuates Collagen-Induced Arthritis","author":"Cao","year":"2020"},{"issue":"10","key":"10.1016\/j.jconrel.2022.05.054_bb1170","first-page":"7728","article-title":"Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-\u03baB and Notch1 pathways","volume":"20","author":"An","year":"2020","journal-title":"Nano Lett."},{"issue":"45","key":"10.1016\/j.jconrel.2022.05.054_bb1175","first-page":"23013","article-title":"A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment: Via inhibiting JAK-STAT and JNK signalling pathways","volume":"12","author":"Wang","year":"2020","journal-title":"Nanoscale."},{"issue":"18","key":"10.1016\/j.jconrel.2022.05.054_bb1180","first-page":"21076","article-title":"Dual-stimuli responsive polymeric micelles for the effective treatment of rheumatoid arthritis","volume":"13","author":"He","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1185","first-page":"185","article-title":"A model for biocompatibility and its evaluation","volume":"II","author":"Williams","year":"1989","journal-title":"J. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.jconrel.2022.05.054_bb1190","first-page":"839","article-title":"Germs and joints: The contribution of the human microbiome to rheumatoid arthritis","volume":"21","author":"Rogers","year":"2015","journal-title":"Nat Med [Internet]."},{"issue":"13","key":"10.1016\/j.jconrel.2022.05.054_bb1195","first-page":"1220","article-title":"Polymeric carriers\u202f: Preclinical safety and the regulatory implications for design and development of polymer therapeutics \u2606","volume":"61","author":"Gaspar","year":"2009","journal-title":"Adv Drug Deliv Rev [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1200","series-title":"Biocompatibility and Immunocompatibility Assessment of Poly ( 2-Oxazolines)","author":"Kronek","year":"2012"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1205","first-page":"1341","article-title":"Effect of molecular weight (mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats","volume":"21","author":"Duncan","year":"1987","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1210","first-page":"1","article-title":"Introduction to dendrimersand other dendritic polymers","volume":"29","author":"Malkoch","year":"2020","journal-title":"R Soc Chem."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1215","first-page":"1","article-title":"Confined microenvironments from thermoresponsive dendronized polymers","volume":"2000325","author":"Xu","year":"2020"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1220","series-title":"Multimechanophore Graft Polymers: Mechanochemical Reactions at Backbone \u2212 Arm Junctions","author":"Peterson","year":"2019"},{"issue":"11","key":"10.1016\/j.jconrel.2022.05.054_bb1225","first-page":"1085","article-title":"Expert opinion on drug delivery amphiphilic block copolymers in drug delivery\u202f: advances in formulation structure and performance and performance","volume":"15","author":"Bodratti","year":"2018","journal-title":"Expert Opin Drug Deliv [Internet]."},{"issue":"8","key":"10.1016\/j.jconrel.2022.05.054_bb1230","first-page":"886","article-title":"Polymer-drug conjugates: recent development in clinical oncology","volume":"60","author":"Li","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"May","key":"10.1016\/j.jconrel.2022.05.054_bb1235","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1240","article-title":"The biocompatibility of polyaniline and polypyrrole: A comparative study of their cytotoxicity, embryotoxicity and impurity profile","volume":"2018","author":"Bober","year":"2017","journal-title":"Mater Sci Eng C [Internet]"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1245","first-page":"677","article-title":"Comparison of haemocompatibility improvement of four polymeric biomaterials by two heparinization techniques","volume":"24","author":"Michanetzis","year":"2003"},{"issue":"January","key":"10.1016\/j.jconrel.2022.05.054_bb1250","first-page":"1","article-title":"Nanoparticle-induced complement activation\u202f: implications for cancer nanomedicine","volume":"11","author":"La-beck","year":"2021"},{"issue":"April 2003","key":"10.1016\/j.jconrel.2022.05.054_bb1255","first-page":"119","volume":"277","author":"Hoste","year":"2004","journal-title":"Polymeric Prodrugs."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1260","series-title":"Mechanically-Induced Chemical Changes in Polymeric Materials","first-page":"5755","author":"Caruso","year":"2009"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1265","series-title":"Toxicological Considerations when Creating Nanoparticle-Based Drugs and Drug Delivery Systems","first-page":"47","author":"Sharma","year":"2012"},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb1270","first-page":"662","article-title":"In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems","volume":"6","author":"Semete","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol Med [Internet]."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1275","first-page":"263","article-title":"The influence of surface modification on the cytotoxicity of PAMAM dendrimers","volume":"252","author":"Jevprasesphant","year":"2003"},{"issue":"5","key":"10.1016\/j.jconrel.2022.05.054_bb1280","first-page":"849","article-title":"Next-generation nanomedicines and nanosimilars: EU regulators\u2019 initiatives relating to the development and evaluation of nanomedicines","volume":"8","author":"Ehmann","year":"2013","journal-title":"Nanomedicine."},{"issue":"January","key":"10.1016\/j.jconrel.2022.05.054_bb1285","first-page":"1","article-title":"Joint MHLW\/EMA reflection paper on the development of 5 block copolymer micelle medicinal products","volume":"44","author":"Agency","year":"2013"},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb1290","first-page":"504","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1295","series-title":"Consultation : Proposed Regulatory Options for Medical Devices Containing Nanomaterials","first-page":"1","author":"Australia","year":"2021"},{"key":"10.1016\/j.jconrel.2022.05.054_bb1300","series-title":"Basic Fundamentals of Drug Delivery","first-page":"733","article-title":"Clinical aspects and regulatory requirements for nanomedicines [Internet]","author":"Tambe","year":"2018"},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb1305","first-page":"127","article-title":"Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties","volume":"2","author":"Nijhara","year":"2006","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2022.05.054_bb1310","first-page":"143","article-title":"Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals","volume":"2","author":"Gaspar","year":"2007","journal-title":"Nanomedicine."},{"issue":"3","key":"10.1016\/j.jconrel.2022.05.054_bb1315","first-page":"218","article-title":"Nanomedicine: an unresolved regulatory issue","volume":"46","author":"Chan","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.054_bb1320","article-title":"Mesenchymal stem cells for cartilage regeneration","volume":"11","author":"Le","year":"2020","journal-title":"J Tissue Eng."},{"issue":"8","key":"10.1016\/j.jconrel.2022.05.054_bb1325","first-page":"886","article-title":"Mesenchymal stem cells for regenerative medicine","volume":"8","author":"Han","year":"2019","journal-title":"Cells."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:29:29Z","timestamp":1759163369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":265,"alternative-id":["S0168365922003261"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.054","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}